Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Nov-Dec;26(6):242-9.
doi: 10.5830/CVJA-2015-055. Epub 2015 Jul 14.

Lack of cardioprotection by single-dose magnesium prophylaxis on isoprenaline-induced myocardial infarction in adult Wistar rats

Affiliations

Lack of cardioprotection by single-dose magnesium prophylaxis on isoprenaline-induced myocardial infarction in adult Wistar rats

Christie Garson et al. Cardiovasc J Afr. 2015 Nov-Dec.

Abstract

Aim: Magnesium (Mg(2+)) is effective in treating cardiovascular disorders such as arrhythmias and pre-eclampsia, but its role during myocardial infarction (MI) remains uncertain. In this study, we investigated the effects of Mg(2+)pre-treatment on isoprenaline (ISO) -induced MI in vivo.

Methods: Rats divided into four groups were each pre-treated with either MgSO4 (270 mg/kg intraperitoneally) or an equivalent volume of physiological saline, prior to the ISO (67 mg/kg subcutaneously) or saline treatments. One day post-treatment, the electrocardiogram and left ventricular blood pressures were recorded. Infarcts were determined using 2,3,5-triphenyltetrazolium chloride staining, and serum markers of lipid peroxidation were measured with spectrophotometric assays.

Results: Mg(2+) pre-treatment neither altered the ISO-induced infarct size compared with ISO treatment alone (p > 0.05), nor reversed the low-voltage electrocardiogram or the prominent Q waves induced by ISO, despite a trend to decreased Q waves. Similarly, Mg(2+) did not prevent the ISO-induced decrease in peak left ventricular blood pressure or the decrease in minimal rate of pressure change. Mg(2+) did not reverse the ISO-induced gain in heart weight or loss of body weight. Neither ISO nor Mg(2+) altered the concentrations of lipid peroxidation markers 24 hours post MI induction.

Conclusion: Although Mg(2+) had no detrimental effects on electrical or haemodynamic activity in ISO-induced MI, the lack of infarct prevention may detract from its utility in MI therapy.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
ISO-induced MI and the effects of Mg2+ pre-treatment. A: Timeline of experimental protocol. The horizontal bar represents a 24-hour timeline with a break in the scale. The times at which rats were treated and at which in vivo and tissue measurements were done are indicated by arrows. B: Pictures of TTC-stained ventricular slices cut from four different hearts of rats treated with saline only (control), ISO and saline (ISO), ISO and Mg2+ (ISO + Mg), or Mg2+ and saline (Mg). Viable myocardium stained red (TTC positive), whereas areas of irreversible infarcts appeared white (TTC negative). C: Summary data of infarct size in whole ventricles. The infarct size is expressed as a percentage of the TTC‑negative area to the total ventricular area. Data are presented as mean ± SEM (n = 8–10 rats per group); *p < 0.05 (treatment vs control).
Fig. 2.
Fig. 2.
Effects of various treatments on the ECG waveforms. Segments of original lead II ECG traces recorded from individual rats under various treatments, A: saline (control), B: ISO, C: ISO + Mg2+, and D: Mg2+.
Fig. 3.
Fig. 3.
Effects of ISO and Mg2+ treatments on haemodynamic parameters in four different groups of rats. A: The maximum left ventricular (LV) blood pressure, B: LV end-diastolic pressure, C: maximal rate of LV pressure change (dP/dt max), D: minimal rate of LV pressure change (dP/dt min), E: systolic duration, and F: diastolic duration. Data are presented as mean ± SEM (n = 8–10 rats per group); *p < 0.05; **p < 0.01 and ***p < 0.001 (treatment vs control).
Fig. 4.
Fig. 4.
Effects of ISO and Mg2+ on the plasma concentrations of markers of lipid peroxidation in four different groups of rats. Plasma concentrations of conjugated dienes (A), and thiobarbituric acid-reactive substances (B), measured 24 hours after administration of the drugs. Data are presented as mean ± SEM (n = 8–10 rats per group).

Similar articles

Cited by

References

    1. James MFM. Magnesium: an emerging drug in anaesthesia. Br J Anaesth. 2009;103:465–467. PMID:19749114. - PubMed
    1. Horner SM. Efficacy of intravenous magnesium in acute myocardial infarction in reducing arrhythmias and mortality. Meta-analysis of magnesium in acute myocardial infarction. Circulation. 1992;86:774–779. PMID:1387591. - PubMed
    1. Woods KL, Fletcher S, Roffe C, Haider Y. Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet. 1992;339:1553–1558. PMID:1351547. - PubMed
    1. Shechter M, Hod H, Chouraqui P, Kaplinsky E, Rabinowitz B. Magnesium therapy in acute myocardial infarction when patients are not candidates for thrombolytic therapy. Am J Cardiol. 1995;75:321–323. PMID:7856520. - PubMed
    1. Collins R Peto R Flather M Parish S Sleight P Conway M et al.ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative. Lancet 1995345669–685.PMID:7661937 - PubMed

Publication types

MeSH terms